Clinical Trials
8 trialsNCT05091866 2026-05-05
Natural Progesterone for the Treatment of Recurrent Glioblastoma
Emory University
Phase EARLY_PHASE1 Terminated
NCT01165632 2025-09-02
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01957956 2023-11-18
Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03360708 2023-06-28
Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT05017610 2022-12-02
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
Emory University
Phase EARLY_PHASE1 Withdrawn
NCT03020017 2022-08-26
NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
Northwestern University
Phase EARLY_PHASE1 Completed
NCT01086345 2018-07-03
Radiosurgery Plus Bevacizumab in Glioblastoma
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT01996527 2017-04-17
3T MRI Biomarkers of Glioma Treatment Response
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated